12TH INTERNATIONAL WORKSHOP ON

LONDON, UK • 10 SEPTEMBER 2019

CLINICAL PHARMACOLOGYOF TUBERCULOSIS DRUGS

The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field. Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed. We look forward to seeing you in London!

WHO SHOULD ATTEND?

• Pharmacists/pharmacologists involved in clinical management of TB-infected patients

• Preclinical and clinical pharmacology researchers from academia and Industry

• PhD and PharmD students• Representatives from regulatory or non-governmental

organizations active in the TB-field

ORGANIZING COMMITTEE

Rob Aarnoutse, PharmD, PhD Radboudumc The Netherlands

Geraint Davis, MD University of Liverpool United Kingdom

Helen McIlleron, MBCHB, PhD University of Cape Town South Africa

Jerry Nedelman, PhD TB Alliance USA

Eric Nuermberger, MD Johns Hopkins University USA

Charles Peloquin, PharmD University of Florida USA

Registration and information: www.expertmedicalevents.com

ORGANIZED BY

FORMAT

This one-day program consists of two to three plenary lectures from invited speakers, and ample time for oral and poster abstract presen-tations.

There is also one highly-rated guided poster tour after the lunch break, where delegates are invited to further explore the content of the accepted abstracts in an informal setting.

Our workshop involves a strong community of clinical pharmaco-logists and other healthcare professionals working in the TB-field. Also, the workshop provides an independent scientific platform to discuss controversial topics and views.

JOIN US AT THE 12TH EDITION OF:

ABOUT THE WORKSHOP

INTERNATIONAL WORKSHOP ON CLINICAL PHARMACOLOGY OF TUBERCULOSIS DRUGS

The treatment of Tuberculosis (TB) is becoming a challenge worldwide. All around the world experts in the field are involved in intensive research to be able to cope with the various concerns with regard to treatment.

The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field. Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed.

Topics will include:- Pharmacokinetics and pharmacodynamics of new TB drugs- Pharmacokinetics and pharmacodynamics of approved TB drugs- Pharmacokinetic – pharmacodynamic modeling- Drug-drug and drug-disease internactions- New TB drug development tools- New developments in pediatric TB- Interactions between TB and HIV drugs- Treatment of MDR- and XDR-TB

ABSTRACT SUBMISSION IS OPEN! SUBMIT YOUR ABSTRACT BEFORE 19 JULY 2019!FOR MORE INFORMATION VISIT WWW.EXPERTMEDICALEVENTS.COM

2018 EDITION IN NUMBERSDelegates from 14 countries43 abstract submissions20 oral abstract presentations